D

Daewoong Co Ltd
KRX:003090

Watchlist Manager
Daewoong Co Ltd
KRX:003090
Watchlist
Price: 20 900 KRW -1.88% Market Closed
Market Cap: 854.6B KRW
Have any thoughts about
Daewoong Co Ltd?
Write Note

Daewoong Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daewoong Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
D
Daewoong Co Ltd
KRX:003090
Operating Income
â‚©233.1B
CAGR 3-Years
13%
CAGR 5-Years
21%
CAGR 10-Years
12%
Yuhan Corp
KRX:000100
Operating Income
â‚©72.6B
CAGR 3-Years
-5%
CAGR 5-Years
44%
CAGR 10-Years
0%
SK Biopharmaceuticals Co Ltd
KRX:326030
Operating Income
-â‚©37.5B
CAGR 3-Years
46%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Operating Income
â‚©262.4B
CAGR 3-Years
68%
CAGR 5-Years
25%
CAGR 10-Years
16%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Operating Income
â‚©4.2B
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
-14%
C
Celltrion Pharm Inc
KOSDAQ:068760
Operating Income
â‚©29.3B
CAGR 3-Years
-15%
CAGR 5-Years
24%
CAGR 10-Years
15%
No Stocks Found

Daewoong Co Ltd
Glance View

Market Cap
854.6B KRW
Industry
Pharmaceuticals

Daewoong Co., Ltd. engages in the management of its subsidiaries. The company is headquartered in Seongnam, Gyeonggi-Do. The firm operates its business mainly through subsidiaries including Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd, Daewoong Development Co Ltd, and Hanall Biopharma Co Ltd. Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd and Hanall Biopharma Co Ltd are engaged in the manufacture and sale of pharmaceuticals. Daewoong Development Co Ltd is engaged in real estate rental and supply business. In addition, IDS&Trust Co Ltd manufactures and sells communication-related devices. Daewoong Life Science Co Ltd is engaged in food processing and sales. Pampaeg Co Ltd is engaged in the packaging business of quasi-drugs. Daewoong Management Development Institute Co Ltd is engaged in management and industrial training projects.

Intrinsic Value
24 259.07 KRW
Undervaluation 14%
Intrinsic Value
Price
D

See Also

What is Daewoong Co Ltd's Operating Income?
Operating Income
233.1B KRW

Based on the financial report for Sep 30, 2024, Daewoong Co Ltd's Operating Income amounts to 233.1B KRW.

What is Daewoong Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
12%

Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for Daewoong Co Ltd have been 13% over the past three years , 21% over the past five years , and 12% over the past ten years .

Back to Top